Prothena Corp Plc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.93

+0.44 (+5.18%)

As of Jun 21, 10:21 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 67%

Hold 3 25%

Sell 1 8%

Price Target

Analyst Price Target +51.4% upside

Low Target $9.22

Average Target $13.52

High Target $14.31

Current Price $8.93

Current
$8.93

Target
$13.52

$9.22 $13.52 avg $14.31

Scenario Analysis

Bear Case

$9.22

3.2%

Low target

Base Case

$13.52

+51.4%

Avg target

Bull Case

$14.31

+60.2%

High target

Risk/Reward

18.6x

Highly favorable

Price in Context

52-Week High

$11.80

-24.3% from high

52-Week Low

$5.64

+58.3% from low

Target vs 52W High

$13.52

+14.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%